Allay Tx is developing a drug-eluting biopolymer for sustained post-operative orthopedic pain management.
allaytx.com
Menlo Park, CA
CEO: Adam Gridley
Arboretum lead: Paul McCreadie
Allay Therapeutics
IN THE NEWS
Allay Therapeutics Appoints Nicole Vitullo to Board Of Directors
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the appointment of Nicole Vitullo, venture partner at Arboretum Ventures, to…
Read More
Allay Therapeutics Completes Oversubscribed $60M Financing Led by Arboretum Ventures
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the completion of its oversubscribed $60M Series C financing, led by…
Read More
